A Registry for People With T-cell Lymphoma

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMemorial Sloan Kettering Cancer Center

About this trial

The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more about how to improve outcomes for people with T-cell lymphoma.

Eligibility criteria

Qualifiers

Written informed consent

Adequate fresh or archival tumor biopsy or intent to obtain fresh tumor biopsy.

T-cell prolymphocytic leukemia

T-cell large granular lymphocytic leukemia

Disqualifiers

Patients with of mycosis fungoides, primary cutaneous anaplastic large cell lymphoma, and/or primary cutaneous acral CD8+ T-cell lymphoma not receiving systemic therapy.

Inability to collect prospective data, measure response, or perform adequate follow-up assessments in the clinical judgment of the treating physician. NOTE: Repository participation does not exclude participation in clinical trials, nor does existing clinical trial participation exclude enrollment in the study herein outlined.

Trial design

Treatments tested in this trial

  • Optional Blood Sample and Nail Sample

Treatment groups

1,000 Participants
are divided into 1 treatment group

Locations

26
California
City of Hope Cancer Center (Data collection only)91010, Duarte United States
UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only)92103, San Diego United States
University of California San Francisco (Data collection only)94143, San Francisco United States
Stanford University Medical Center (Data collection only)94305-5408, Stanford United States

Sponsors and collaborators

Memorial Sloan Kettering Cancer Center

Lead sponsor